Wei Song
Education
Ph.D., health services research and policy, University of Rochester; Master of Management, social medicine and health management and Bachelor of Management, public administration, Shanghai University of Finance and Economics
Summary of Experience
Dr. Song is an expert in health economics and outcomes research (HEOR). Her research experience includes cost-effectiveness analyses, budget impact models, trial data analyses, indirect treatment comparisons, systematic literature reviews, and real-world evidence (RWE) analyses. Dr. Song has supported submissions of economic models to health technology assessment agencies in the UK and Canada. She is experienced in studying economic and clinical outcomes using real-world data such as administrative claims databases, electronic medical records, and medical chart review data. She has conducted research across a variety of therapeutic areas, including oncology, urology, rheumatology, hematology, gastroenterology, cardiology, neurology, infectious diseases, cell and gene therapy, and vaccines.
-
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
Prostate Cancer and Prostatic Diseases, 2024
2024George DJ, Agarwal N, Ramaswamy K, Klaassen Z, Bitting RL, Russell D, Sandin R, Emir B, Yang H, Song W, Lin Y, Hong A, Gao W, Freedland SJ
-
Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis
Advances in Therapy, 2023
2023Toro W, Yang M, Georgieva M, Song W, Patel A, Jiang AX, Zhao A, LaMarca N, Dabbous O
-
Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-Jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides Difficile Infection in the USA
Advances in Therapy, 2023
2023Lodise T, Guo A, Yang M, Cook EE, Song W, Yang D, Wang Q, Zhao A, Bochan M
-
Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-Jslm [FMBL]) for Preventing Recurrent Clostridioides Difficile Infection in the US
Advances in Therapy, 2023
2023Lodise T, Guo A, Yang M, Cook EE, Song W, Yang D, Wang Q, Zhao A, Bochan M
-
December 4, 2024
-
April 16, 2024
-
April 11, 2024
